Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 APR 6 ... paternal chromosome, and pN792S in the maternal chromosome. Management Low-dose disodium pamidronate (0.1 mg/kg per week for 4 weeks), which commenced on the seventh day after birth and was ...
2009 JUN 22 ... (mouse-derived osteoblasts) and MLC-6 cells (mouse-derived osteoclasts) in vitro. N-BPs (pamidronate and zoledronic acid) inhibited both androgen receptor transactivation and tumor cell ...
2009 SEP 28 ... serum calcium and PTH-rP levels. Treatment of hypercalcemia was successful in all cases; pamidronate was utilized in 8 patients," wrote P. Savvari and colleagues, University of Athens, ...
2009 AUG 11 ... who improved dramatically after treatment with a combination of isotretinoin and pamidronate," wrote H. Galadari and colleagues. The researchers concluded: "This ...
2009 JUN 1 ... hypercalcemia who was not a surgical candidate was managed with the bisphosphonate pamidronate. This patient had failed conventional measures to manage hypercalcemia and presented ...
2009 OCT 19 ... calcium concentration of 14.4 mg/dL." "Intravenous crystalloid fluids and pamidronate were administered with achievement of normocalcemia, and the patient was discharged. ...
2009 MAY 4 ... in Ferrara, Italy conducted a study "To evaluate the efficacy of intravenous (i.v) pamidronate in patients with SAPHO syndrome refractory to first line treatments and to review the ...
2009 FEB 23 ... patients, all treated with the low- and medium-potency bisphosphonates clodronate or pamidronate, were selected as having an established bisphosphonate-related osteonecrosis of the ...
2009 JUL 20 ... switching from an early generation bisphosphonate (i.e., oral clodronate or intravenous pamidronate) to intravenous zoledronic acid. with progressive bone metastases despite use of an ...
2009 FEB 23 ... of fractures occur following liver transplantation. To analyze the effect of intravenous pamidronate on bone loss after liver transplantation," scientists in Barcelona, Spain report.
...
2009 MAR 16 ... renal failure fed a high-phosphate diet. Daily treatment with either etidronate or pamidronate prevented aortic calcification, with the latter being 100-fold more potent. Both aortic ...
2009 MAR 9 ... = 179/787), 73% had breast cancer. 25% of patients were given zoledronic acid (ZOL), 62% pamidronate (PAM), 8% PAM followed by ZOL and 5% clodronate. ONJ was observed in 28 patients (2.9%); ...
2009 JUN 22 ... calcitonin and two anectodal cases, we launched an open therapeutic trial of IV monthly pamidronate infusions, over a course of 3-6 months in this condition. Of 24 patients, 75% reported ...
2009 AUG 17 ... reduce, and delay multiple myeloma (MM)-related skeletal complications. Intravenous pamidronate and zoledronic acid, and oral clodronate are used for the management of MM bone ...
2009 OCT 12 ... showed no abnormalities. The patient was treated with hydration and a single dose of pamidronate. At the time of discharge 6 days later, her creatinine had fallen to 1.9 mg/dl, and her ...
2009 APR 14 ... disease characterized by bone brittleness and various degrees of growth disorder. Cyclic pamidronate therapy is reportedly useful to prevent bone fracture in OI and in infants with OI, but, ...
2009 MAY 18 ... the injection site (relative potencies of necrotic actions of NBPs: zoledronate >>pamidronate >or=alendronate >risedronate), while non-NBPs lacked this effect. Clodronate, when ...
